Susan Lally-Villa, RN, BSN

Feature Story

05/03/2008

Before FDA approval of the automatic implantable cardioverter-defibrillator, the primary treatment for life-threatening ventricular tachycardia was drug therapy. Unfortunately, many of the antiarrhythmic drugs also had a proarrhythmic side...

Before FDA approval of the...

05/03/2008

EP Lab Digest

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Susan Lally-Villa, RN, BSN

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products